Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

ADVERTISEMENT

Understanding Life-threatening COVID-19 Pneumonia

What causes severe COVID-19 symptoms? Evidences suggest inborn errors of type I Interferon immunity and autoantibodies against type I Interferon are causal for critical COVID-19. These errors can be identified using whole genome sequencing, thereby leading to proper quarantine and treatment.

A recent paper throws light on causal mechanism underlying severe COVID-19 pneumonia.

More than 98% of the infected persons do not get any symptoms of the disease or develop mild disease. Less than 2% of the infected persons develop severe pneumonia 1-2 weeks after infection and need to be hospitalised for acute respiratory distress and/or organ failure. Less than 0.01% of the infected persons develop severe systemic inflammation resembling Kawasaki disease (KD).

Advanced age was found to be major risk for life-threatening COVID-19 pneumonia. Most of the persons requiring hospitalisation are more than 67 years of age – critical disease was found to be 3.5 times higher in persons more than 75 years of age than persons less than 45 years. Men are at higher risk of developing severe symptoms.

People with comorbidities like hypertension, diabetes, chronic cardiac disease, chronic pulmonary disease, and obesity are at higher risk of developing severe symptoms.

Some genotypes were causal for the severe COVID-19 phenotype. Inborn errors of interferon immunity play key role in development of severe symptoms. Patients with deleterious variants at 13 loci (that code for immunologically connected proteins) have defective interferons. These errors disrupt type I Interferon immunity thus causing excessive inflammation and critical COVID-19 symptoms. Further, neutralising autoantibodies against type I interferons are present in at least 10% of patients with severe life-threatening illness.

This paper concludes that inborn errors of type I Interferon immunity and autoantibodies against type I Interferon are causal for critical COVID-19.  

Perhaps identifying people with such genotypes will go a long way in preventing and treating severe outcome of the disease. Whole genome sequencing of people can be used to identify the vulnerable patients leading to their proper quarantine and treatment.

*** 

Source(s):  

Zhang Q., Bastard P., Bolze A., et al., 2020. Life-Threatening COVID-19: Defective Interferons Unleash Excessive Inflammation. Med. Volume 1, Issue 1, 18 December 2020, Pages 14-20. DOI: https://doi.org/10.1016/j.medj.2020.12.001  

*** 

Umesh Prasad
Umesh Prasad
Science journalist | Founder editor, Scientific European magazine

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Most Popular Articles

A New Antibody Approach to Fight Ovarian Cancer

A unique immunotherapy-based antibody approach has been developed which...

COVID-19 Not Over Yet: What We Know of the Latest Surge in China 

It is perplexing why China chose to lift zero-COVID...

Airborne Transmission of Coronavirus: Acidity of aerosols controls infectivity 

Coronaviruses and influenza viruses are sensitive to acidity of...
- Advertisement -
93,100FansLike
47,343FollowersFollow
1,772FollowersFollow
30SubscribersSubscribe